Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

BMRN $128.78 13.2300 +11.45%
CALA $17.45 1.5700 +9.89%
VICL $0.92 0.0677 +7.92%
MRTX $28.42 2.0500 +7.77%
NLNK $52.26 3.3300 +6.81%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

OHRP $2.74 -5.9900 -68.61%
LOXO $12.37 -1.0450 -7.79%
IMDZ $24.09 -1.5600 -6.08%
CNDO $3.58 -0.2200 -5.79%
MEIP $1.74 -0.0900 -4.92%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

FDA Approves New Treatment For Diabetic Retinopathy in Patients With Diabetic Macular Edema

( Mar 25, 2015 - The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema.
read press release 

Amgen’s Icelandic DNA Quest

(Bloomberg) Mar 25, 2015 - Researchers now know more about the DNA of Icelanders than any other nation on earth. To find new drugs and understand human evolution, scientists at Amgen Inc.’s DeCode Genetics have sequenced the genomes of more than 1 in every 100 people in the country.
read article 

House Passes Boehner-Pelosi Medicare Deal in Resounding Vote

(The Hill) Mar 26, 2015 - The House on Thursday overwhelmingly voted to repeal automatic cuts to doctors under Medicare, endorsing a rare bipartisan deal that Speaker John Boehner (R-Ohio) negotiated with Democrats.
read article 

Steven L. D’Amato, BSPharm, BCOP, Becomes President of the Association of Community Cancer Centers

(ACCC) Mar 23, 2015 - Steven L. D’Amato, BSPharm, BCOP, became President of the Association of Community Cancer Centers (ACCC) at its 41st Annual Meeting, CANCERSCAPE on March 18, 2015.
read press release 

Pathway Genomics Launches Updated Next Generation Sequencing Tests for Colorectal Cancer

(Morningstar) Mar 26, 2015 - Pathway Genomics Corporation announced it has launched ColoTrue™, a comprehensive panel that combines next-generation sequencing with deletion/duplication analysis to detect pathogenic variants in 15 high-risk colorectal cancer susceptibility genes.
read article 

Amgen to Appeal Rejection of Bid to Block Novartis Biosimilar Drug

(Reuters) Mar 25, 2015 - Amgen Inc will appeal the rejection of its bid to block the sale of Novartis AG's biosimilar form of Neupogen, Amgen's blockbuster drug used to prevent infections in cancer patients, according to a court filing on Wednesday.
read article 

Stada Agrees Oncology Deal With Indian Hetero Drugs

(Reuters) Mar 26, 2015 - German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.
read article 

Medica and Minnesota Oncology Collaborate to Improve Patient Support Services

(The US Oncology Network) Mar 26, 2015 - Minnesota Oncology, the premier cancer physician group throughout the Twin Cities and an affiliate of The US Oncology Network, today announced that as of January 1, 2015, select Medica members have access to a comprehensive cancer care management program.
read corporate press release 

Susan G. Komen® Supports Bill For Treatment Affordability

(Susan G. Komen) Mar 25, 2015 - Susan G. Komen®, the world’s largest breast cancer organization, today pledged support for bipartisan legislation aimed at reducing out-of-pocket costs for patients who need expensive specialty drugs.
read press release 

CANCERSCAPE—ACA’s Impact on the Frontline of Care

(ACCCBuzz) Mar 24, 2015 - March 23 marked the five-year anniversary of President Obama’s signing of the Affordable Care Act into law.
read article 

FDA: Don’t Use Treanda Injection (Solution) With Certain CSTDs

(ACCC) Mar 25, 2015 - The U.S. Food and Drug Administration (FDA) is warning healthcare professionals not to use Treanda Injection (45 mg/0.5 mL or 180 mg/2 mL solution) with closed system transfer devices (CSTD), adapters, and syringes containing polycarbonate or acrylonitrile-butadiene-styrene (ABS).
read article 

Healthcare Professionals Are Overmedicating Senior Cancer Patients, and Here's What Can Be Done

(Forbes) March 25, 2015 - Overmedicating senior cancer patients has become an area of concern for many in the medical community. Instead of strictly blaming healthcare professionals for their lack of oversight, experts point to the failures of available medication management tools.
read article 

Immune Design Announces Treatment of Patients With CMB305 Investigational Immuno-Oncology Agent

(MarketWatch) Mar 26, 2015 - Immune Design today announced the dosing of patients in a Phase 1b clinical trial of CMB305, a "prime-boost" immuno-oncology product candidate generated from the company's ZVexTM and GLAASTM platforms.
read article 

Galena Biopharma Expands Patient Population in NeuVax(TM) (nelipepimut-S) and Trastuzumab Phase 2b Combination Clinical Trial in HER2 1+/2+ Patients

(The Street) Mar 26, 2015 - Galena Biopharma, Inc. today announced that human leukocyte antigen (HLA) - A24+ or HLA-A26+ women are now eligible for enrollment into the ongoing Phase 2b clinical trial with NeuVax™ (nelipepimut-S) in combination with trastuzumab (Herceptin®; Genentech/Roche).
read article 

ASTRO Joins National Launch of Health Care Payment Learning and Action Network (HCPLAN) Today

(StreetInsider) Mar 25, 2015 - The American Society for Radiation Oncology (ASTRO) leadership participated in today’s launch of the new Health Care Payment Learning and Action Network (HCPLAN) from the U.S. Department of Health and Human Services (HHS) at an event featuring President Obama and HHS Secretary Burwell.
read article 

DSMB Recommends Continuation of EFFIKIR Trial With Two Arms

(Innate Pharma) Mar 26, 2015 - Innate Pharma SA today announces that the Data and Safety Monitoring Board (“DSMB”) completed its fourth assessment of the EffiKIR study and recommended to stop treatment in one arm and continue the trial with the remaining two arms as per protocol.
read corporate press release 

Cellular Biomedicine Group Announces Phase I Results From CAR-T Immuno-Oncology Clinical Development Programs

(NASDAQ) Mar 25, 2015 - Cellular Biomedicine Group Inc. today announced clinical data from its CAR-T immuno-oncology clinical development programs.
read article 

Emotion, Values Called Valid in Cancer-Treatment Decisions

(Cornell Chronicle) Mar 25, 2015 - The doctor says: “We offer two kinds of surgery for your cancer.”
read article 

Blocking Cellular Quality Control Mechanism Gives Cancer Chemotherapy a Boost

(URMC) March 26, 2015 - A University of Rochester team found a way to make chemotherapy more effective, by stopping a cellular quality-control mechanism, according to a study published today in Nature Communications.
read press release 

Blood Test Could Help Bowel Cancer Patients Avoid Drug Side-Effects

(University of Manchester [UK]) Mar 25, 2015 - Manchester researchers have provided early evidence to suggest that a blood test could be used to identify bowel cancer patients that may benefit from more intensive chemotherapy.
read press release 

Could a Tampon Help Predict Endometrial Cancer? Mayo Clinic Researchers Say Yes

(Mayo Clinic) Mar 24, 2015 - Researchers at Mayo Clinic have shown that it is possible to detect endometrial cancer using tumor DNA picked up by ordinary tampons.
read press release 

Cancer Immunotherapy 'Has Entered Mainstream'

(Medscape Medical News) Mar 25, 2015 - Cancer immunotherapy takes centre stage in a series of articles about harnessing the immune system for therapy published March 25 as a special issue of Science Translational Medicine.
read article (free registration required) 

Budesonide Has Potential For Lung Cancer Chemoprevention

(Medscape Medical News) Mar 26, 2015 - Inhaled glucocorticosteroids might have potential as a chemopreventive agent for lung cancer, new research shows.
read article (free registration required) 

How Men Can Protect Against Cancer

(TIME) Mar 26, 2015 - It’s no surprise that being physically fit helps protect against heart disease, but a person’s level of fitness might also have a profound effect on cancer outcomes long before a diagnosis.
read article 

New Program Assigns Personal Guides to Cancer Patients

(Stanford Medicine) Mar 26, 2015 - A new program assigns special nurses to serve as one-on-one advocates and liaisons for cancer patients new to Stanford Health Care.
read article